Is pharma quality ready for AI?
Table of contents
Let’s turn your AI vision into results
Whether you're scaling or just starting out, we’re here to help you do it right.
Deviation management is one of the most crucial tasks in pharma quality. It’s also where some of the worst bottlenecks arise. And when the process breaks down, the impacts are very real.
We asked 230 quality professionals across 100 European pharma companies and CDMOs to share their problems and priorities in deviation management. Where does the time go? Where do investigations stall? Does standardisation really help? How much has been automated so far? And how could AI play a larger role?
This indispensable report reveals what quality professionals really think about deviation management today, what they’d like to change, and where they see the most exciting opportunities for AI.